Press Release – New York, NY – September 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio (Nasdaq: INMB), a clinical-stage inflammation and immunology …
Sichenzia Ross Ference Carmel LLP Represents INmune Bio Inc. in $9.7 Million Registered Direct Offering
Press Release – New York, NY – April 29, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on …
Sichenzia Ross Ference Carmel LLP Represents INmune Bio Inc. in $4.8 Million Registered Direct Offering
Press Release – New York, NY – April 24, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on …
Sichenzia Ross Ference LLP Represents Inmune Bio, Inc. in a $40.0 Million Registered Direct Offering
Press Release – New York, New York – July 16, 2021 - Sichenzia Ross Ference LLP announced today that it represented Inmune Bio, Inc. (Nasdaq: INMB), a clinical-stage immunology company focused on …
Sichenzia Ross Ference LLP Represents INmune Bio, Inc. in $21.74 Million Public Offering of Common Stock
Press Release – New York, NY – July 17, 2020 – Sichenzia Ross Ference LLP announced that it represented INmune Bio Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing …